A detailed history of Stock Yards Bank & Trust CO transactions in Gamida Cell Ltd. stock. As of the latest transaction made, Stock Yards Bank & Trust CO holds 100,000 shares of GMDA stock, worth $3,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Previous 100,000 -0.0%
Holding current value
$3,000
Previous $41,000 90.24%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$0.25 - $1.02 $12,500 - $51,000
50,000 Added 100.0%
100,000 $41,000
Q4 2022

Feb 02, 2023

SELL
$1.15 - $2.1 $23,000 - $42,000
-20,000 Reduced 28.57%
50,000 $65,000
Q3 2022

Nov 03, 2022

BUY
$1.53 - $3.39 $53,550 - $118,650
35,000 Added 100.0%
70,000 $111,000
Q2 2022

Aug 24, 2022

BUY
$1.73 - $4.29 $60,550 - $150,150
35,000 New
35,000 $62,000

Others Institutions Holding GMDA

About Gamida Cell Ltd.


  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Stock Yards Bank & Trust CO Portfolio

Follow Stock Yards Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stock Yards Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Stock Yards Bank & Trust CO with notifications on news.